<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(10)</volume><submitter>Shen HF</submitter><pubmed_abstract>To master the technology of reprogramming mouse somatic cells to induced pluripotent stem cells (iPSCs), which will lay a good foundation for setting up a technology platform on reprogramming human cancer cells into iPSCs. Mouse iPSCs (i.e., Oct4-GFP miPSCs) was successfully generated from mouse embryonic fibroblasts (MEFs) harboring Oct4-EGFP transgene by introducing four factors, Oct4, Sox2, c-Myc and Klf4, under mESC (Murine embryonic stem cells) culture conditions. Oct4-GFP miPSCs were similar to mESCs in morphology, proliferation, mESC-specific surface antigens and gene expression. Additionally, Oct4-GFP miPSCs could be cultured in suspension to form embryoid bodies (EBs) and differentiate into cell types of the three germ layers &lt;i>in vitro&lt;/i>. Moreover, Oct4-GFP miPSCs could develo</pubmed_abstract><journal>Aging</journal><pagination>4445-4458</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9186763</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells.</pubmed_title><pmcid>PMC9186763</pmcid><pubmed_authors>Xia JW</pubmed_authors><pubmed_authors>Li YL</pubmed_authors><pubmed_authors>Lin XL</pubmed_authors><pubmed_authors>Yao ZF</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Tian YG</pubmed_authors><pubmed_authors>Li YC</pubmed_authors><pubmed_authors>Zhao WT</pubmed_authors><pubmed_authors>Shi JW</pubmed_authors><pubmed_authors>Huang SH</pubmed_authors><pubmed_authors>Xiao GF</pubmed_authors><pubmed_authors>Xiao D</pubmed_authors><pubmed_authors>Jia JS</pubmed_authors><pubmed_authors>Shen HF</pubmed_authors></additional><is_claimable>false</is_claimable><name>A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells.</name><description>To master the technology of reprogramming mouse somatic cells to induced pluripotent stem cells (iPSCs), which will lay a good foundation for setting up a technology platform on reprogramming human cancer cells into iPSCs. Mouse iPSCs (i.e., Oct4-GFP miPSCs) was successfully generated from mouse embryonic fibroblasts (MEFs) harboring Oct4-EGFP transgene by introducing four factors, Oct4, Sox2, c-Myc and Klf4, under mESC (Murine embryonic stem cells) culture conditions. Oct4-GFP miPSCs were similar to mESCs in morphology, proliferation, mESC-specific surface antigens and gene expression. Additionally, Oct4-GFP miPSCs could be cultured in suspension to form embryoid bodies (EBs) and differentiate into cell types of the three germ layers &lt;i>in vitro&lt;/i>. Moreover, Oct4-GFP miPSCs could develo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T08:46:43.326Z</modification><creation>2025-04-04T08:46:43.326Z</creation></dates><accession>S-EPMC9186763</accession><cross_references><pubmed>35575836</pubmed><doi>10.18632/aging.204083</doi></cross_references></HashMap>